Thermo Fisher Scientific (TMO) Tops Q3 EPS by $1.09
Tweet
Share
E-mail
Get Alerts TMO Hot Sheet
Price: $607.28 -1.06%
EPS Growth %: +10.7%
Financial Fact:
Income from Continuing Operations: 473.5M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +10.7%
Financial Fact:
Income from Continuing Operations: 473.5M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Thermo Fisher Scientific (NYSE: TMO) reported Q3 EPS of $5.76, $1.09 better than the analyst estimate of $4.67. Revenue for the quarter came in at $9.33 billion versus the consensus estimate of $8.39 billion.
GUIDANCE:
Thermo Fisher Scientific sees FY2021 EPS of $23.37, versus the consensus of $22.19. Thermo Fisher Scientific sees FY2021 revenue of $37.1 billion, versus the consensus of $36.1 billion.
For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
- HSBC lifts S&P 500 year-end target
- UBS upgrades Lockheed Martin to Buy, sees 26% upside on missile growth
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
